Hirayama K, Koshizaka M, Ishibashi R, Shoji M, et al. Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub-analysis of a randomized controlled study. Diabetes Obes Metab 2025;27:2059-2069.
PMID: 39806556